Drug_ID,Drug,Y,Permeability,Binary
(-)-epicatechin,Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2,-6.2199998,6.025598635633657e-07,0
"(2E,4Z,8Z)-N-isobutyldodeca-2,4,10-triene-8 -ynamide",C/C=C\C#CCC/C=C\C=C\C(=O)NCC(C)C,-3.8599999,0.00013803845824481443,1
codeine,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,-4.0900002,8.128301418418987e-05,1
danazol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,-4.8400002,1.4454391050964657e-05,1
dexamethasone b D glucuronide,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[C@H]1O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O,-6.119999900000002,7.585777496981427e-07,0
DMXAA-G,Cc1ccc2c(=O)c3cccc(CC(=O)OC4OC(C(=O)O)[C@@H](O)[C@@H](O)[C@@H]4O)c3oc2c1C,-6.52,3.019951720402019e-07,0
d-praeruptorin,C/C=C(\C)C(=O)O[C@H]1[C@@H](OC(C)=O)c2c(ccc3ccc(=O)oc23)OC1(C)C,-4.579999900000002,2.630268597537029e-05,1
EF5154,O=C(O)COc1ccc(C(=O)CN2CCN(C3CCNCC3)CC2=O)cc1,-6.119999900000002,7.585777496981427e-07,0
EF5170,CCCCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCNCC3)CC2=O)cc1,-5.79,1.6218100973589298e-06,0
EF5232,CCCCC(C)OC(=O)COc1ccc(C(=O)CN2CCN(C3CCNCC3)CC2=O)cc1,-5.29,5.128613839913648e-06,0
EF5242,CCCCCCC(C)OC(=O)COc1ccc(C(=O)CN2CCN(C3CCNCC3)CC2=O)cc1,-4.7399998,1.819701696613392e-05,1
EF5248,CCCCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OCc4oc(=O)oc4C)CC3)CC2=O)cc1,-4.3499999,4.4668369500367274e-05,1
EF5249,Cc1oc(=O)oc1COC(=O)N1CCC(N2CCN(CC(=O)c3ccc(OCC(=O)OC4CCCCC4)cc3)C(=O)C2)CC1,-4.3099999,4.897789321441998e-05,1
EF5251,CCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OC(C)OC(C)=O)CC3)CC2=O)cc1,-4.2800002,5.248072185670614e-05,1
EF5261,O=C(COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OC/C=C4/OC(=O)c5ccccc54)CC3)CC2=O)cc1)OC1CCCCC1,-4.4000001,3.981070788859444e-05,1
EF5264,CC(=O)OC(C)OC(=O)N1CCC(N2CCN(CC(=O)c3ccc(OCC(=O)OC4CCOCC4)cc3)C(=O)C2)CC1,-4.5100002,3.090294009380277e-05,1
EF5265,CCOCC(COCC)OC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OC(C)OC(C)=O)CC3)CC2=O)cc1,-4.1500001000000015,7.079456213736132e-05,1
EF5278,CCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OC(OC(=O)C(C)(C)C)C(C)(C)C)CC3)CC2=O)cc1,-4.0,0.0001,1
EF5283,CCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OC(C)OC(=O)C(C)(C)C)CC3)CC2=O)cc1,-4.139999899999999,7.244361268825545e-05,1
elarofiban,O=C(O)C[C@H](NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1)c1cccnc1,-6.21,6.165950018614822e-07,0
eriodictyol ,O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2cc(O)cc(O)c21,-5.2800002,5.248072185670614e-06,0
erythromycin,CC[C@@H]1OC(=O)[C@@H](C)[C@H](O[C@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@H]2O[C@H](C)C[C@@H](N(C)C)[C@H]2O)[C@@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@@]1(C)O,-5.7800002,1.659586143169722e-06,0
famotidine,NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,-6.0700002,8.51137646238915e-07,0
fluparoxan,Fc1cccc2c1O[C@H]1CNC[C@@H]1O2,-4.099999899999999,7.94328417625139e-05,1
glycerol,OCC(O)CO,-4.829999900000002,1.4791087287455338e-05,1
glycine-valine acyclovir,CC(=O)C(NC(=O)CN)c1ccc(O)cc1,-5.2800002,5.248072185670614e-06,0
guanabenz,NC(N)=N/N=C/c1c(Cl)cccc1Cl,-4.6799998,2.0892970930106858e-05,1
hesperetin ,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,-4.7399998,1.819701696613392e-05,1
hexapeptide 01,C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 05,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 06,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 08,C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
aceclofenac,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,-4.4099998,3.890453241562325e-05,1
hexapeptide 12,C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 13,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 14,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 20,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
acetaminophen,CC(=O)Nc1ccc(O)cc1,-4.4400001,3.630779711682995e-05,1
hexapeptide 22,C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 23,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 25,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 26,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.3000002,5.011870028220744e-06,0
hexapeptide 28,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.0,1e-05,1
hexapeptide 29,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 34,C[C@H]1C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N1C,-5.8200002,1.5135605514156553e-06,0
hexapeptide 38,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 48,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
hexapeptide 52,C[C@H]1C(=O)N(C)[C@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N1C,-4.6999998,1.9952632338213456e-05,1
hexapeptide 54,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C1=O,-5.0,1e-05,1
hexapeptide 58,C[C@H]1C(=O)N(C)[C@H](C)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N1C,-5.3000002,5.011870028220744e-06,0
indomethacin,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,-4.6900001,2.041737474542049e-05,1
isoquercitrin ,O=c1c(OC2C(O)OC(CO)C(O)C2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,-6.170000099999998,6.760828197181441e-07,0
ketoconazole,CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,-4.9299998,1.1748980959999732e-05,1
Liquiritin apioside ,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,-7.119999900000002,7.585777496981427e-08,0
lisinopril,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,-7.389999900000001,4.073803716068979e-08,0
loracarbef,N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1.O,-7.3400002,4.5708797911803274e-08,0
LY366659,CC(C)S(=O)(=O)n1c(N)nc2ccc(/C(=C/C(N)=O)c3c(F)c(F)cc(F)c3F)cc21,-4.1999998,6.309576350468559e-05,1
LY366799,CC(C)S(=O)(=O)n1c(N)nc2ccc(/C(=C/C(N)=O)c3ccccc3F)cc21,-4.54,2.8840315031266056e-05,1
LY366853,C.CC(C)n1c(N)nc2ccc(/C(=C/C(N)=O)c3cccc(F)c3F)cc21,-5.3000002,5.011870028220744e-06,0
LY366856,CC(C)S(=O)(=O)n1c(N)nc2ccc(/C(=C/C(N)=O)c3ccc(F)c(F)c3F)cc21,-4.329999900000002,4.677352489872053e-05,1
metolazone,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,-5.21,6.165950018614822e-06,0
amoxicillin,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,-6.1524997,7.038827141612425e-07,0
nadalol,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,-5.4109998,3.881505447405388e-06,0
naproxen,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,-4.6599998,2.187762631451247e-05,1
naproxen sodium,COc1ccc2cc(C(C)C(=O)[O-])ccc2c1.[Na+],-4.329999900000002,4.677352489872053e-05,1
naringenin,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,-4.6550002,2.2130936904380954e-05,1
N-carbobenzoxy-tryptophan,O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)OCc1ccccc1,-5.8000002,1.5848924625909923e-06,0
neolignan smi02,C/C=C/c1cc(OC)c2c(c1)C(C)C(c1cc(OC)c(O)c(OC)c1)O2,-5.3400002,4.570879791180327e-06,0
neolignan smi05,C=CCc1cc(OC)c(OC(C)Cc2cc(OC)c(OC)c(OC)c2)c(OC)c1,-4.73,1.8620871366628657e-05,1
ampicillin,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,-5.6999998,1.9952632338213455e-06,0
oxacillin,Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,-5.579999900000002,2.630268597537029e-06,0
oxprenolol ester,C=CCOc1ccccc1OC[C@@H](CNC(C)C)OC(=O)C1CC1,-4.545000099999998,2.8510176110327788e-05,1
PNU200001,N=C(N)c1ccc2[nH]c(Cc3nc4ccccc4[nH]3)nc2c1,-6.6999998,1.9952632338213456e-07,0
PNU200647,N/C(=N/O)c1ccc2[nH]c(-c3ccccn3)nc2c1,-4.6500001,2.2387206230838082e-05,1
PNU200648,Cc1ccnc2nc(Cc3nc4cc(C(=N)N)ccc4[nH]3)[nH]c12,-7.0500002,8.912505276976144e-08,0
PNU200969,CCOC(=O)NC(=N)c1ccc2[nH]c(Cc3nc4ccccc4[nH]3)nc2c1,-6.1500001,7.079456213736161e-07,0
pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,-5.8400002,1.4454391050964657e-06,0
prazosin,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,-4.987,1.0303861204416158e-05,1
prednisolone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,-4.7199998,1.905461595460538e-05,1
propranolol ester,CC(C)NC[C@H](COc1cccc2ccccc12)OC(=O)C1CC1,-4.5100002,3.090294009380277e-05,1
puerarin ,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,-6.4000001,3.981070788859444e-07,0
quinidine,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,-4.6900001,2.041737474542049e-05,1
raffinose,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,-7.619999900000002,2.3988334713712373e-08,0
artesunate,C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,-5.4000001,3.981070788859444e-06,0
rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,-4.96,1.0964781961431852e-05,1
SACV,C=C1NC(N)=Nc2c1ncn2COCCOC(=O)[C@H](N)CO,-5.329999900000002,4.677352489872053e-06,0
serotonin,NCCc1c[nH]c2ccc(O)cc12,-4.8600001,1.3803839467576993e-05,1
sildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)[nH]c12,-4.5100002,3.090294009380277e-05,1
sulfadiazine,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,-4.75,1.778279410038923e-05,1
sulfasalazine,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,-5.378171,4.18628700939794e-06,0
tenidap,NC(=O)N1C(=O)C(C(=O)c2cccs2)c2cc(Cl)ccc21,-4.5700002,2.691533564429618e-05,1
tryptophan,NC(Cc1c[nH]c2ccccc12)C(=O)O,-5.3899999,4.073803716068988e-06,0
ursolic acid,C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C,-5.5500002,2.8183816333514456e-06,0
benzoic acid,O=C(O)c1ccccc1,-4.0050001,9.885528670342027e-05,1
vinblastine,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,-5.48,3.3113112148259077e-06,0
VLA-4 antagonist 2,CCOC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.369999900000002,4.265796170251665e-06,0
VLA-4 antagonist 3,CC(C)OC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.170000099999998,6.760828197181441e-06,0
VLA-4 antagonist 4,CN(C)C(=O)Oc1ccc(C[C@H](NC(=O)[C@H]2N(S(=O)(=O)c3cnn(C)c3)CSC2(C)C)C(=O)OCC(C)(C)C)cc1,-5.3400002,4.570879791180327e-06,0
VLA-4 antagonist 5,CN(C)C(=O)Oc1ccc(C[C@H](NC(=O)[C@H]2N(S(=O)(=O)c3cnn(C)c3)CSC2(C)C)C(=O)OCOC(=O)C(C)(C)C)cc1,-5.5999999,2.5118870098928704e-06,0
VLA-4 antagonist 6,COCCOCCOC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.6900001,2.041737474542049e-06,0
benzylpenicillin,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,-6.0250001,9.440606589078989e-07,0
CA-DADLE,CC(C)C[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)/C=C\c2ccccc2OC1=O,-5.880000099999998,1.3182564350166154e-06,0
CA-Leu-Enk,CC(C)C[C@H]1NC(=O)[C@@H](CC2CCCCC2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)/C=C\c2ccccc2OC1=O,-6.4699998,3.3884431218273895e-07,0
camptothecin,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,-4.1100001000000015,7.762469378912057e-05,1
carboxamido 28,CC(C)(C)CC(=O)Nc1c(F)cc(C(=O)Nc2nccs2)cc1F,-4.059999899999998,8.709637905028848e-05,1
cefazolin,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,-6.23,5.888436553555884e-07,0
ceftriaxone,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1,-6.764999900000001,1.7179087827206533e-07,0
cephalexin,CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccccc3)C2SC1,-6.3600001,4.36515731728693e-07,0
cephalexin acetylated,CC(=O)NC(C(=O)NC1C(=O)N2C(C(=O)O)=C(C)CSC12)c1ccccc1,-6.630000099999998,2.3442282755413604e-07,0
CFPN-PI,CC/C=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CS[C@H]12)c1csc(N)n1.Cl.O,-5.1100001,7.762469378912089e-06,0
cimetidine,C/N=C(\NC#N)NCCSCc1[nH]cnc1C,-5.9000001,1.2589251219159127e-06,0
clozapine,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,-4.5100002,3.090294009380277e-05,1
2,CN(C(=O)[C@H](Cc1ccc(C(=N)N)cc1)NS(=O)(=O)c1ccc2ccccc2c1)C1CCCC1,-6.6989698,2.0000009410023612e-07,0
34,NCc1cccc(Cc2ncccn2)c1,-4.5968795,2.5299998766394224e-05,1
7,CNS(=O)(=O)c1ccc(Cl)cc1,-4.186419,6.510000171360851e-05,1
Amiloride,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,-6.251812,5.599999651769192e-07,0
Cimetidine,CN/C(=N\CCSCc1nc[nH]c1C)NC#N,-6.0420098,9.078000451359179e-07,0
Lef53,NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1,-7.4317985,3.699998091047198e-08,0
15j,COc1cccc(-n2c(=O)n(Cc3c(F)cccc3Br)c(=O)n(C[C@H](N)c3ccccc3)c2=O)c1F,-4.856985099999998,1.3900003192461148e-05,1
15f,COc1cccc(-n2c(=O)n(Cc3ccccc3C#N)c(=O)n(C[C@H](N)c3ccccc3)c2=O)c1F,-4.5917602,2.5599990255500057e-05,1
32,CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,-4.9586072,1.1000002908762926e-05,1
Lobucavir,Nc1nc(O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2n1,-6.0555172,8.800002590589407e-07,0
Metoprolol,COCCc1ccc(OCC(O)CNC(C)C)cc1,-4.3493013,4.4740280233566185e-05,1
9,CC(C)CNC(=O)[C@H](C)NC[C@H](Cc1ccccc1)NC(=O)c1cc(CCC2C[C@@H]2C)cc(N(C)S(C)(=O)=O)c1,-4.6197886,2.4000008747341526e-05,1
4b,CC(C)CNC(=O)[C@H](C)NC[C@H](Cc1ccccc1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccc(F)cc2)cc(N(C)S(C)(=O)=O)c1,-5.0,1e-05,1
2n,CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.5528421,2.799999153205545e-05,1
2k,C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F,-4.6382723,2.2999992796583263e-05,1
2i,Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1,-4.6382723,2.2999992796583263e-05,1
2m,COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.5376019,2.900000681779469e-05,1
2e,C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F,-4.5528421,2.799999153205545e-05,1
2h,CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.6020598,2.500001101372527e-05,1
2o,CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.6020598,2.500001101372527e-05,1
2l,COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.6020598,2.500001101372527e-05,1
2d,Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1,-4.5086384000000015,3.09999933020973e-05,1
1,COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.468521099999999,3.399999866579783e-05,1
49,O=C(N[C@@H]1CCOC[C@@H]1C(=O)NO)c1ccc(Cc2c(C(F)(F)F)nn3ccccc23)cc1,-5.7447276,1.7999995643833021e-06,0
48,CC(C)(C)c1nn2ccccc2c1Cc1ccc(C(=O)N[C@@H]2CCOC[C@@H]2C(=O)NO)cc1,-5.3665314,4.300001429923486e-06,0
17,Cc1ccc(C(F)(F)CNc2ccc(C#N)c(CC(=O)NCCONC(=N)N)c2F)nc1,-6.188375,6.480745992913409e-07,0
22,N#Cc1ccc(NCC(F)(F)c2cccc(F)c2)c(F)c1CC(=O)NCCONC(=N)N,-5.741402099999998,1.8138355101771474e-06,0
34,CN(OCCNC(=O)Cc1c(C#N)ccc(NCC(F)(F)c2ccccn2)c1F)C(=N)N,-6.3723636,4.242642127548507e-07,0
S-6j,c1csc([C@]23CNC[C@H]2C3)c1,-4.7544875,1.759999319924939e-05,1
659-Harmane,Cc1nccc2c1[nH]c1ccccc12,-5.223299,5.979997466579685e-06,0
795-Coptisine chloride (COP),[Cl-].c1c2c(cc3c1OCO3)-c1cc3ccc4c(c3c[n+]1CC2)OCO4,-4.9574246,1.1029997144299092e-05,1
"877-(2S,4S,5R)-2-[(4'-Chlorophenyl)-4-methyl-1,3-dioxan-5-yl]amine (5h)",C[C@@H]1O[C@@H](c2ccc(Cl)cc2)OC[C@H]1N,-4.9279342,1.1804994796962263e-05,1
"878-(2S,4S,5R)-2-[(4'-Nitrophenyl)-4-methyl-1,3-dioxan-5-yl]amine (5i)",C[C@@H]1O[C@@H](c2ccc(N(O)O)cc2)OC[C@H]1N,-4.8885694000000015,1.2925001435488471e-05,1
"879-(cis)-[2-(E-Phenylvinyl)-1,3-dioxan-5-yl]amine (6a)",C=C(c1ccccc1)C1OCC(N)CO1,-4.9913998,1.0200000663210017e-05,1
"880-(2S,4S,5R)-[2-(E-Phenylvinyl)-4-methyl-1,3-dioxan-5-yl]amine (6b)",C=C(c1ccccc1)[C@H]1OC[C@@H](N)[C@H](C)O1,-4.9880071,1.027999491889327e-05,1
881-13h,C[C@@H]1O[C@@H](c2ccc(Cl)cc2)OC[C@H]1NC(=O)Cc1ccccc1,-4.9920392,1.0184994527841173e-05,1
"883-(cis)-[2-(E-Phenylvinyl)-1,3-dioxan-5-yl]phenylacetamide (14a)",C=C(c1ccccc1)C1OCC(NC(=O)Cc2ccccc2)CO1,-5.0498786,8.915001077462758e-06,1
732-Amitriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,-3.9006648,0.00012569997751497102,1
808-Asn-Ala-NH2,CC(NC(=O)C(N)CC(N)=O)C(N)=O,-6.5885487000000005,2.578999749769474e-07,0
016-Ceftibuten,Nc1nc(/C(=C\CC(=O)O)C(=O)NC2C(=O)N3C(C(=O)O)=CCSC23)cs1,-6.0604806,8.700002952416597e-07,0
107-zidovudine,Cc1cn([C@H]2C[C@H]([N-][NH+]=N)[C@@H](CO)O2)c(=O)[nH]c1=O,-5.1850867,6.530001785134059e-06,0
150-Artesunate,C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](OC(=O)CCC(=O)O)O[C@@H]3OC4(C)CC[C@@H]1[C@@]23OO4,-5.4001169,3.98000025592479e-06,0
167-cephradine,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@@H](N)C3=CCC=CC3)[C@H]2SC1,-5.6925039,2.030000290209044e-06,0
174-Guanabenz,NC(N)=N/N=C/c1c(Cl)cccc1Cl,-4.363411900000001,4.330999165004551e-05,1
205-Fluoxetine,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,-4.9299622,1.1749998197902349e-05,1
243-Famotidine,NC(N)=Nc1nc(CSCC/C(N)=N\S(N)(=O)=O)cs1,-5.9488473,1.1250004599338594e-06,0
263-Amrinone,Nc1cc(-c2ccncc2)c[nH]c1=O,-4.7544875,1.759999319924939e-05,1
285-Ephedrine,CN[C@@H](C)[C@@H](O)c1ccccc1,-4.9913998,1.0200000663210017e-05,1
403-Atorvastatin,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@H](O)C[C@H](O)CC(=O)O,-5.309804,4.899999097065019e-06,0
Acrivastine,Cc1ccc(/C(=C/CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1,-5.720623000000002,1.902729274142177e-06,0
Aminopyrine,Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C,-4.389419599999999,4.079250730696948e-05,1
Amphetamine sulfate,C[C@H](N)Cc1ccccc1,-4.3899999,4.073803716068987e-05,1
Ampicillin,CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O,-6.0700002,8.51137646238915e-07,0
Artesunate,CC1CCC2C(C)C(OC(=O)CCC(=O)O)OC3OC4(C)CCC1C32OO4,-5.4000001,3.981070788859444e-06,0
Atorvastatin,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,-5.3099999,4.8977893214419975e-06,0
Bicalutamide,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,-4.6599998,2.187762631451247e-05,1
Bisoprolol,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,-4.7600002,1.7378000284627016e-05,1
Bupropion,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,-3.9519544,0.00011169805222107722,1
Camazepam,CN(C)C(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2N(C)C1=O,-4.46,3.467368504525317e-05,1
Cefuroxime,CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(N)=O)CSC12)c1ccco1,-6.29,5.128613839913648e-07,0
Celecoxib,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,-4.8050604,1.566533187569059e-05,1
Cetirizine,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,-5.5,3.162277660168379e-06,0
Chloroquine,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,-4.5500002,2.8183816333514456e-05,1
Chlorpheniramine,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,-4.2800002,5.248072185670614e-05,1
Chlorprothixene,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,-4.7399998,1.819701696613392e-05,1
Chlorzoxazone,O=c1[nH]c2cc(Cl)ccc2o1,-4.190000100000002,6.4565408036729e-05,1
Clarithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,-5.4699998,3.38844312182739e-06,0
Clozapine,CN1CCN(C2=c3ccccc3=Nc3ccc(Cl)cc3N2)CC1,-4.5100002,3.090294009380277e-05,1
Codeine,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,-4.2800002,5.248072185670614e-05,1
Dextromethorphan,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,-4.7399998,1.819701696613392e-05,1
Diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,-4.460681,3.4619357216927135e-05,1
Digoxin,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H]6C[C@@H](O)[C@]7(C)C(C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,-5.6316042,2.3355856594001654e-06,0
Diltiazem,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,-4.4043612,3.941293707962827e-05,1
Enalaprilat,C[C@H](N[C@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@@H]1C(=O)O,-5.880000099999998,1.3182564350166154e-06,0
Exemestane,C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,-4.329999900000002,4.677352489872053e-05,1
Ethionamide,CCc1cc(C(N)=S)ccn1,-4.4000001,3.981070788859444e-05,1
Fluoxetine,CNCCC(Oc1ccc(C)cc1)c1ccccc1,-4.5500002,2.8183816333514456e-05,1
Fluparoxan (GR50360A),Fc1cccc2c1O[C@H]1CNC[C@H]1O2,-3.729485,0.00018642965676628117,1
Flupenthixol,OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,-4.8899999,1.2882498483235886e-05,1
Fluvastatin,CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,-5.6999998,1.9952632338213455e-06,0
Gancyclovir,Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,-6.1012278,7.920857496434847e-07,0
Glutaminic Acid,NC(CCC(=O)O)C(=O)O,-6.0700002,8.51137646238915e-07,0
Grepafloxacin HCl,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,-4.8899999,1.2882498483235886e-05,1
Isoxicam,Cc1cc(NC(O)=C2C(=O)c3ccccc3S(=O)(=O)N2C)no1,-4.6100001,2.4547083504674815e-05,1
Ketanserin,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,-4.4400001,3.630779711682995e-05,1
Labetalol,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,-4.895062,1.2733212883423216e-05,1
Lamivudine,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,-5.420000099999998,3.80189308778729e-06,0
Lomefloxacin,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,-4.8000002,1.5848924625909923e-05,1
Loperamide HCl,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,-4.9699998,1.0715197986905956e-05,1
Lobucavir,Nc1nc2c(ncn2C2[C@@H](CO)C[C@@H]2CO)c(=O)[nH]1,-6.0599999,8.709637905028812e-07,0
Lovastatin,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,-4.8400002,1.4454391050964657e-05,1
Loxoprofen,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,-4.3499999,4.4668369500367274e-05,1
Mebendazole,COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,-4.5100002,3.090294009380277e-05,1
Methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,-5.1161518,7.65329052840841e-06,0
Metolazone,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N[C@H]1C,-5.3049202000000015,4.955412363038174e-06,0
Nelfinavir,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,-6.1500001,7.079456213736161e-07,0
Nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1N(O)O,-4.6999998,1.9952632338213456e-05,1
Olopatadine,CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21,-5.0100002,9.772367709215421e-06,1
Ouabain,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,-6.9593034,1.0982383373298067e-07,0
Pentoxifylline,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,-4.1799998,6.606937522682428e-05,1
Phenobarbital,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,-4.630000099999998,2.3442282755413603e-05,1
Piroxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,-4.4490995,3.5554985020024984e-05,1
Prazocin,COc1cc2nc(N3CCN(C(=O)c4occc4Cl)CC3)nc(N)c2cc1OC,-4.8899999,1.2882498483235886e-05,1
Promazine,CN(C)CCCN1c2ccccc2Sc2ccccc21,-4.380000099999998,4.168692874826252e-05,1
Pyrimethamine,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,-4.23,5.888436553555884e-05,1
Quinidine,C=C[C@H]1CN2CC[C@H]1C[C@@H]2C(O)c1ccnc2ccc(OC)cc12,-4.6799998,2.0892970930106858e-05,1
Remikiren (Ro 42-5892),CC(C)(C)S(=O)(=O)C[C@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](CC1CCCCC1)[C@@H](O)[C@H](O)C1CC1,-6.1300907,7.41155438923371e-07,0
Rifampicin,CO[C@@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)/C(=C\NN2CCN(C)CC2)C(=C4O)NC(=O)C(C)=CC=C[C@@H](C)[C@H](O)[C@H](C)[C@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C,-5.399786,3.983033874789619e-06,0
Rofecoxib,NS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,-4.619999900000002,2.3988334713712372e-05,1
Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,-6.2800002,5.248072185670614e-07,0
Sorivudine (BVaraU),O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br,-5.3899999,4.073803716068988e-06,0
Sparfloxacin (SPX),C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,-4.7784066,1.6656870143282763e-05,1
Tacrolimus,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,-5.1500001,7.0794562137361614e-06,0
Trazodone,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,-4.619999900000002,2.3988334713712372e-05,1
Triazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,-4.5500002,2.8183816333514456e-05,1
Valproic acid,CCCC(CCC)C(=O)O,-4.3200002,4.78629871905386e-05,1
Yohimbine (YOH),COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,-4.8099999,1.5488169755407276e-05,1
Zolpidem,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,-4.5,3.1622776601683795e-05,1
Zomepirac,Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1,-4.6100001,2.4547083504674815e-05,1
Gly-Pro (glycylproline),NCC(=O)N1CCC[C@H]1C(=O)O,-5.2123351,6.132886113521532e-06,0
DMP 851,CCCCN1C(=O)N(Cc2ccc3[nH]nc(N)c3c2)[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@H]1Cc1ccccc1,-5.6788902000000006,2.094641964343459e-06,0
N-Acetyl-D-valyl-D-phenylalanine N-Methylamide (3a),CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(C)=O)C(C)C,-5.3900242,4.073575781648922e-06,0
N-Acetyl-D-phenylalanyl-D-phenylalanine N-Methylamide (5a),CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(C)=O,-5.0499268,8.914011704524573e-06,1
N-Acetyl-D-phenylalanine Phenethylamide (11a),CC(=O)N[C@H](Cc1ccccc1)C(=O)NCCc1ccccc1,-4.4210458,3.79274985132507e-05,1
N-Acetyl-D-cyclohexylalanine Phenethylamide (12),CC(=O)N[C@H](CC1CCCCC1)C(=O)NCCc1ccccc1,-4.351765599999999,4.4487131127358296e-05,1
1,CC1CCN(C(=O)CC(Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,-6.8762317,1.3297447979283446e-07,0
2,N=C(N)c1cccc(CC(CC(=O)N2CCCCC2C(=O)O)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.3814997999999985,4.1543224255543635e-08,0
3,COC(=O)C1CCCCN1C(=O)CC(Cc1cccc(C(=N)N)c1)NS(=O)(=O)c1ccc2ccccc2c1,-7.1178856,7.622797800695237e-08,0
4,N=C(N)c1cccc(CC(CC(=O)N2CCCC(C(=O)O)C2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.382024799999999,4.149303477294859e-08,0
6,N=C(N)c1cccc(CC(CC(=O)N2CCC(C(=O)O)CC2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.3390937,4.5804305224618876e-08,0
8,N=C(NO)c1cccc(CC(CC(=O)N2CCC(C(=O)O)CC2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.3677616,4.287838308099735e-08,0
9,CNC(=N)c1cccc(CC(CC(=O)N2CCC(C(=O)O)CC2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.1487603,7.099695130681551e-08,0
13,CC1CCN(C(=O)CC(Cc2cccc(N)c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,-4.997839,1.0049882866675561e-05,1
16,CNC(=N)c1cccc(CC(CC(=O)N2CCC(C)CC2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-6.850390400000001,1.411268343895389e-07,0
Alprenolol ester,C=CCc1ccccc1OCC(CNC(C)C)OC(=O)C1CC1,-4.1507826,7.066712126264766e-05,1
Betaxolol ester,CC(C)NCC(COc1ccc(CCOCC2CC2)cc1)OC(=O)C1CC1,-4.1300812,7.411716515486122e-05,1
Oxprenolol ester,C=CCOc1ccccc1OCC(CNC(C)C)OC(=O)C1CC1,-4.1920457,6.426200920428316e-05,1
V,CCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5500002,2.8183816333514456e-05,1
VIII,CCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5700002,2.691533564429618e-05,1
XIV,CCCCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.77,1.698243652461746e-05,1
Gomisin A,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)C[C@H](C)[C@@](C)(O)C2,-4.5693183,2.6957629489726532e-05,1
Epinephrine,CNCC(O)c1ccc(O)c(O)c1,-6.0188646,9.57492542235848e-07,0
Fleroxacin,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1,-4.8099742,1.5489086317226516e-05,1
Ceftriaxone,CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1,-6.604713,2.484774606075209e-07,0
BVaraU,O=c1[nH]c(=O)n([C@H]2O[C@@H](CO)[C@H](O)[C@H]2O)cc1/C=C/Br,-5.3989701,3.990523750927213e-06,0
Glutamine,NC(=O)CC[C@H](N)C(=O)O,-6.0702906,8.5056870566199e-07,0
Dexamethasone-?-D-glucoside,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O,-6.3982739,3.9969259290667755e-07,0
Lactulose,OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,-6.5364394,2.9077736721541386e-07,0
PNU 200603,N=C(N)c1ccc2nc(-c3ccccn3)[nH]c2c1,-6.4579659000000005,3.483646669119414e-07,0
L-alanine,C[C@H](N)C(=O)O,-5.4201083,3.8009460032401872e-06,0
Tiotidine,C/N=C(\NC#N)NCCSCc1csc(N=C(N)N)n1,-5.6587887000000014,2.1938720739768917e-06,0
Glycylsarcosine,CN(CC(=O)O)C(=O)CN,-4.9000001,1.2589251219159127e-05,1
MEN15596,Cc1ccc2cc(C(=O)NC3(C(=O)N[C@H](Cc4ccccc4)C(=O)NCC4CCN(CC5CCOCC5)CC4)CCCC3)sc2c1,-5.291214900000001,5.1142870493443505e-06,0
9-Nitrocamptothecin (9-NC),CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N(O)O)cccc3nc2-1,-5.198543099999998,6.330775310815924e-06,0
H 95/71,CC(C)NCC(O)COc1ccc(NC=O)cc1,-5.4279842,3.7326373719867305e-06,0
Oxacillin,Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,-4.879711599999999,1.3191324381592218e-05,1
Cyclo(-PFwKTF-) (1),C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,-6.2209244,6.012783961709453e-07,0
Cyclo(-PFwKTMeF-) (3),C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C1=O,-6.3005152,5.005930318198145e-07,0
Cyclo(-PFMewKTF-) (4),C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,-6.3989701,3.990523750927213e-07,0
Cyclo(-PFMewMeKTF-) (6),C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)N(C)C(=O)[C@@H](Cc2c[nH]c3ccccc23)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,-6.742363900000001,1.8098229870351425e-07,0
Ac-D-phe2-NH2,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O,-5.6994848,1.9976306828816265e-06,0
Ac-D-phe2-(NMe-D-phe)-NH2,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O,-5.3484769,4.4825289180639924e-06,0
Ac-D-phe-(NMe-D-phe)2-NH2 {[14C]-Acf(N-Mef)2NH2 },CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O,-4.922927400000002,1.1941877173669026e-05,1
Ac-(NMe-D-phe)3-NH2,CC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O,-4.6937804000000005,2.0240423723115e-05,1
Ac-(NMe-D-phe)3-NHMe,CNC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](Cc1ccccc1)N(C)C(C)=O,-4.494889700000001,3.199707652689641e-05,1
BMS 189664,CS(=O)(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC1CCN(C(=N)N)CC1,-6.561124799999999,2.747104624486107e-07,0
PNU200969,CCOC(=O)NC(=N)c1ccc2nc(Cc3nc4ccccc4[nH]3)[nH]c2c1,-6.152451,7.039616491043236e-07,0
PNU-93936A,CC(=O)NCC1CN(c2cc(F)c(-c3ccncc3)c(F)c2)C(=O)O1,-4.29,5.128613839913648e-05,1
PNU-100766,CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,-4.6788902000000006,2.0946419643434594e-05,1
PNU-184435,CC(=S)NC[C@H]1CN(c2ccc(N3CCCS(=O)CC3)c(F)c2)C(=O)O1,-5.338621099999999,4.5854176678295764e-06,0
PNU-184249,CCC(=S)NC[C@H]1CN(c2ccc(N3CCN(C=O)CC3)c(F)c2)C(=O)O1,-4.4579659000000005,3.483646669119414e-05,1
PNU-184148,O=C(CO)N1CCN(c2ccc(N3C[C@H](CNC(=S)C4CC4)OC3=O)cc2F)CC1,-4.4308991,3.7076685234951906e-05,1
PNU-184147,CCC(=S)NC[C@H]1CN(c2ccc(N3CCN(C(=O)CO)CC3)c(F)c2)C(=O)O1,-4.7423639,1.809822987035146e-05,1
PNU-184421,CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(C#N)nc3)c(F)c2)C(=O)O1,-4.3783755,4.184316240249067e-05,1
PNU-179962,CC(=O)NC[C@H]1CN(c2ccc(-c3nnc(CC/C(C)=N\O)s3)c(F)c2)C(=O)O1,-5.250906,5.611694240816571e-06,0
PNU-179399,NC(=S)NC[C@H]1CN(c2ccc(C3CCS(=O)(=O)CC3)c(F)c2)C(=O)O1,-5.8880281,1.2941121062699004e-06,0
"NK1NK2 analogue 105 (MDL 105,212)",COc1cc(C(=O)N2CC[C@](CCN3CCC(C(N)=O)(c4ccccc4)CC3)(c3ccc(Cl)c(Cl)c3)C2)cc(OC)c1OC,-5.4105153,3.8858380807980755e-06,0
NK1NK2 analogue 212 (15d),COc1cc(C(=O)N2CC[C@](CCN3CCC(C(=O)N4CCOCC4)(c4ccccc4)CC3)(c3ccc(Cl)c(Cl)c3)C2)cc(OC)c1OC,-5.0814137000000015,8.29060645111183e-06,1
366094,CNC(=O)C(c1ccc2nc(N)n(C(C)C)c2c1)c1cccc(F)c1F,-5.0,1e-05,1
"EI analogue 101 (MDL 101,146)",CC(C)C(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(C(=O)N2CCOCC2)cc1)C(C)C)C(=O)C(F)(F)C(F)(F)F,-5.098455,7.971590850093219e-06,0
354400,CC(C)NS(=O)(=O)n1c(N)nc2ccc(C(C(N)=O)c3cc(F)ccc3F)cc21,-4.5388007,2.892006734847612e-05,1
"EI analogue 102 (MDL 102,111)",CC(C)C(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)N1CCOCC1)C(C)C)C(=O)C(F)(F)C(F)(F)F,-4.517849900000001,3.0349399328884857e-05,1
Thiamin (Vitamin B1),Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,-5.2685814,5.387888504847471e-06,0
6MAQH (W2),O=C(CS)NCCCCCC(=O)Nc1cccc2cccnc12,-4.8496218,1.413768171304363e-05,1
Bicyclol,COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2,-4.7979398,1.5924294473524644e-05,1
5'-L-phenylalanyl-floxuridine,NC(Cc1ccccc1)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-5.3891382000000005,4.081894727279004e-06,0
5'-L-isoleucyl-floxuridine,CCC(C)C(N)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-5.5908804000000005,2.5651903649194083e-06,0
Lithospermic acid (LSA),O=C(/C=C/c1ccc(O)c2c1C(C(=O)O)C(c1ccc(O)c(O)c1)O2)OC(Cc1ccc(O)c(O)c1)C(=O)O,-7.0891552,8.144131923305519e-08,0
14,CCCCCCC(N)C(=O)N[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,-6.222376799999998,5.992709147652078e-07,0
Epimedin A,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)ccc3c(=O)c2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1,-6.4910722000000005,3.2279574400126475e-07,0
Epimedin B,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@@H]2O[C@H]2OC[C@H](O)[C@@H](O)[C@@H]2O)cc1,-6.5595455000000005,2.7571125810864784e-07,0
Icariin,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@@H]2O)cc1,-6.2292061,5.899210591509881e-07,0
Baohuoside I,COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O[C@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@@H]2O)cc1,-5.8378239,1.452700546801047e-06,0
Umbelliferone,O=c1ccc2ccc(O)cc2o1,-4.5710139000000005,2.685258500080043e-05,1
"8-Hydroxy-pentadeca-(9E,13Z)-dien-11-yn-2-one (2)",C/C=C\C#C/C=C/C(O)CCCCCC(C)=O,-4.3099017,4.898896904687232e-05,1
"Tetradec-(8Z)-ene-11,13-diyn-2-one (6)",C#CC#CC/C=C\CCCCCC(C)=O,-4.492425,3.217918199499838e-05,1
SB639,O=C(/C=C/c1ccc2c(c1)nc(CCc1ccccc1)n2CCN1CCCC1)NO,-5.5207167,3.014972116570295e-06,0
PB-26,Cn1cncc1CN1CC(N(Cc2cccc(-n3cccc3)c2)S(=O)(=O)c2ccccn2)Cc2cc(C#N)ccc21,-5.6391363,2.295428132498951e-06,0
MEN14268,O=C(NC1(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCN2CCOCC2)CCCC1)c1cc2ccccc2s1,-5.0478787,8.956148790538294e-06,1
MEN14745,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCCN2CCOCC2)CCCC1)c1cc2ccccc2o1,-5.2209244,6.012783961709454e-06,0
MEN15353,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NC2CCN(CC3CCOCC3)CC2)CCCC1)c1cc2ccccc2s1,-5.0700002,8.51137646238915e-06,1
MEN15716,CCN(CC)c1ccc2cc(C(=O)NC3(C(=O)N[C@H](Cc4ccccc4)C(=O)NCC4CCN(CC5CCOCC5)CC4)CCCC3)sc2c1,-4.997839,1.0049882866675561e-05,1
-,Nc1cccnc1,-4.5380535,2.8969866908462757e-05,1
-,NC(=O)c1ccncc1,-4.2782722,5.268995164389268e-05,1
-,c1ccc(-c2ccncc2)cc1,-4.0680037,8.55059428119408e-05,1
-,Nc1ccncc1,-4.0202255,9.544968511268604e-05,1
-,CCc1ccncc1,-3.9723473,0.00010657435182751282,1
-,c1ccncc1,-3.9703081,0.00010707594106589406,1
-,c1ccc(-c2cccnc2)cc1,-3.8880284,0.00012941112123292348,1
4'-Cl BZT,CN1C2CC[C@@H]1CC(OC(c1ccccc1)c1ccc(Cl)cc1)C2,-4.9114642,1.226127971362996e-05,1
"3',4''-diCl BZT",CN1C2CC[C@@H]1CC(OC(c1ccc(Cl)cc1)c1cccc(Cl)c1)C2,-5.5975828000000005,2.5259060900068217e-06,0
"5,7-DMF",COc1cc(OC)c2c(=O)cc(-c3ccccc3)oc2c1,-4.6313224,2.337101639097565e-05,1
"5,7,4'-TMF",COc1ccc(-c2cc(=O)c3c(OC)cc(OC)cc3o2)cc1,-4.5595455000000005,2.7571125810864785e-05,1
"7,4'-DHF",O=c1cc(-c2ccc(O)cc2)oc2cc(O)ccc12,-5.2123351,6.132886113521532e-06,0
"Chrysin (5,7-DHF)",O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,-5.0105972,9.758943418333445e-06,1
"Apigenin (5,7,4'-THF)",O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,-4.9821801,1.0418852745798686e-05,1
12d,Cn1cnc(S(=O)(=O)N(CCN(Cc2cncn2C)c2ccc(C#N)cc2)Cc2ccccc2)c1,-5.9593034000000005,1.0982383373298045e-06,0
Biotin-Saquinavir,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1CC(OC(=O)CCCCC1SCC2NC(=O)NC21)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,-6.4094677,3.895222767608435e-07,0
G6191,CN1C(=O)CN(CCC(=O)O)C(=O)c2cc(NCc3ccc(C(=N)N)cc3)ccc21,-6.4579659000000005,3.483646669119414e-07,0
G6262,CCOC(=O)CCN1CC(=O)N(C)c2ccc(OCc3ccc(C(=N)N)cc3)cc2C1=O,-6.3682656,4.28286514560761e-07,0
XP13512,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,-4.5093193,3.095142865722042e-05,1
Harmol,Cc1nccc2c1[nH]c1cc(O)ccc12,-5.302258999999999,4.985870566463234e-06,0
CF 1525 (p-Me),COC(=O)C(C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(C)cc1,-5.8474512,1.4208518595473559e-06,0
CF 1517 (p-Br),COC(=O)C(C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(Br)cc1,-5.6954093,2.0164650542637095e-06,0
Roxithromycin,CC[C@@H]1OC(=O)[C@@H](C)[C@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@H](C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@@]1(C)O,-5.7397189000000015,1.820879053383543e-06,0
"2-Amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP)",Cn1c(N)nc2ncc(-c3ccccc3)cc21,-4.820511799999999,1.511778623015518e-05,1
10,COc1cc(C)ccc1S(=O)(=O)NC(=O)C(c1ccc2c(c1)OCO2)c1cn(C)c2cc(F)ccc12,-4.6994848,1.9976306828816264e-05,1
11,COc1cc(C)ccc1S(=O)(=O)NC(=O)C(c1ccc2c(c1)OCO2)c1cn(C)c2cc(C(C)=O)ccc12,-5.8519359,1.4062550660205124e-06,0
15,COCCn1cc(C(C(=O)NS(=O)(=O)c2ccc(C)cc2OC)c2ccc3c(c2)OCO3)c2ccc(COC)cc21,-5.7979398,1.5924294473524644e-06,0
16,COCCn1cc(C(C(=O)NS(=O)(=O)c2ccc(C)cc2OC)c2ccc3c(c2)OCO3)c2ccc(F)cc21,-5.720623000000002,1.902729274142177e-06,0
21c,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCCN2CCC(O)CC2)CCCC1)c1cc2ccccc2s1,-5.8519359,1.4062550660205124e-06,0
25a,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCCC(=O)N2CCC(N3CCOCC3)CC2)CCCC1)c1cc2ccccc2s1,-5.769775900000001,1.6991201881437624e-06,0
25f,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N2CCN(C3CCOCC3)CC2)CCCC1)c1cc2ccccc2s1,-5.8880281,1.2941121062699004e-06,0
48d,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCC2CCN(CC3CCOCC3)CC2)CCCC1)c1cc2ccc(C(F)(F)F)cc2s1,-5.1919103,6.428204729575615e-06,0
20E 22-ethyl ether (5),CCO[C@H](CCC(C)(C)O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.8600001,1.3803839467576993e-05,1
20E 22-allyl ether (7),C=CCO[C@H](CCC(C)(C)O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.6900001,2.041737474542049e-05,1
20E 25-methyl ether (10),COC(C)(C)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.7600002,1.7378000284627016e-05,1
PoA 22-methyl ether (18),CO[C@H](CCC(C)C)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.579999900000002,2.630268597537029e-05,1
"(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-yl linoleate (1)",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC/C=C/c1ccc(OC)c(OC)c1,-4.8498521,1.413018669501661e-05,1
"(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-yl oleate (2)",CCCCCCCC/C=C\CCCCCCCC(=O)OCC/C=C/c1ccc(OC)c(OC)c1,-5.0101638,9.768687123039499e-06,1
Compound D,COc1ccc(/C=C/CCO)cc1OC,-4.8428431,1.4360081343529173e-05,1
Rutaecarpine (RCP),O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12,-5.0582528,8.74474601057068e-06,1
Evodiamine (EDM),CN1c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)C21,-4.632256,2.3320829832472595e-05,1
YH439,Cc1csc(NC(=O)C(C(=O)OC(C)C)=C2SCS2)n1,-4.5100002,3.090294009380277e-05,1
Choline,C[N+](C)(C)CCO,-4.9521427000000005,1.1164963303751869e-05,1
Rebaudioside A,C=C1C[C@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OC4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)C2CC(O[C@H]2O[C@@H](CO)[C@H](O)C(O[C@H]4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)[C@@H]2O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]1C3,-6.9593034,1.0982383373298067e-07,0
D-Phe-D-Ala-D-Ser-OH,C[C@H](NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CO)C(=O)O,-6.2819986,5.22397873008183e-07,0
Carbendazim,COC(=O)Nc1nc2ccccc2[nH]1,-4.1011863,7.921614428207836e-05,1
Dexloxiglumide,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1,-5.140130999999999,7.242174751454299e-06,0
Imidacloprid (IMI),ON(O)NC1=NCCN1Cc1ccc(Cl)nc1,-4.6677732,2.148952420619597e-05,1
Laudanosine (LAU),COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2C)cc1OC,-4.5497985,2.8196908823211663e-05,1
Cepharanthine (CEP),COc1ccc2cc1Oc1ccc(cc1)CC1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)C5C2)OCO4)CCN1C,-4.1877432,6.490180870039629e-05,1
Corynanthine (COR),COC(=O)[C@H]1[C@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]21,-4.729893700000001,1.8625429658230488e-05,1
Ac-Gly-Asn-Ala-NH2,CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O,-6.5900002,2.5703945990581314e-07,0
Ac-Gly-Lys-Ala-NH2,CC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O,-7.0100002,9.772367709215421e-08,0
Brucine N-oxide (B-N),COc1cc2c(cc1OC)[C@]13CC[N+]4([O-])CC5=CCO[C@@H]6CC(=O)N2[C@@H]1[C@@H]6[C@@H]5C[C@H]34,-5.46,3.467368504525317e-06,0
Pseudostrychnine (Psd),O=C1C[C@H]2OCC=C3CN4C[C@H](O)C56c7ccccc7N1[C@@H]5[C@H]2[C@H]3CC46,-4.6001629999999984,2.5109438437501632e-05,1
Biliverdin,C=CC1=C(C)/C(=C\C2=N/C(=C\c3[nH]c(/C=C4/NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O,-5.6290045,2.3496084749416575e-06,0
16,COc1cnn(C)c(=O)c1-c1ccc(C[C@@H](CO)NC(=O)c2c(Cl)cccc2Cl)cc1,-5.6010299,2.505936720130149e-06,0
TMC435350 (32c),COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,-5.0778604000000005,8.35871658373556e-06,1
32f,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1Cl,-5.238286,5.777154737432874e-06,0
32g,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-n3ccc(C(C)C)n3)nc2c1C,-4.8219547,1.5067642242039618e-05,1
32h,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3cccc(C(C)C)n3)nc2c1C,-4.9204097,1.201130790291211e-05,1
DXG (9),COc1ccc(-c2cc(=O)c3c(O)cc(OC4O[C@H](CO[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,-6.1599998,6.918312895189466e-07,0
DG (13),COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,-6.9204097,1.201130790291211e-07,0
Kaempferol (16),O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,-4.9899998,1.0232934635247014e-05,1
Quercitrin (21),C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@H](O)[C@@H]1O,-6.0999999,7.943284176251373e-07,0
Isoquercitrin (22),O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,-6.27,5.370317963702533e-07,0
IRR (23),COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2OC2O[C@H](CO[C@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O)[C@H]2O)ccc1O,-6.5388007,2.892006734847612e-07,0
Eriodictyol (28),O=C1CC(c2ccc(O)c(O)c2)Oc2cc(O)cc(O)c21,-5.2800002,5.248072185670614e-06,0
Isoliquiritigenin (35),O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,-4.8378239,1.4527005468010471e-05,1
7d,Cc1ccc(N2CCN(C(=O)[C@H](C)Cc3ccc(Cl)cc3)CC2)c([C@@H](N)C(C)C)c1,-5.3000002,5.011870028220744e-06,0
9,CNCCN[C@H](c1cc(C)ccc1N1CCN(C(=O)[C@H](C)Cc2ccc(Cl)cc2F)CC1)C(C)C,-5.52,3.0199517204020193e-06,0
10c,CNCC(=O)N[C@H](c1cccc(F)c1N1CCN(C(=O)[C@H](C)Cc2ccc(Cl)cc2Cl)CC1)C(C)C,-5.6999998,1.9952632338213455e-06,0
10d,CC(C)[C@H](NC(=O)CCN(C)C)c1cccc(F)c1N1CCN(C(=O)[C@H](C)Cc2ccc(Cl)cc2)CC1,-5.0,1e-05,1
11b,Cc1ccc(N2CCN(C(=O)[C@H](C)Cc3ccc(Cl)cc3)CC2)c([C@@H](NC(=O)CCN)C(C)C)c1,-5.521439099999999,3.009961218413622e-06,0
11c,CNCCC(=O)N[C@H](c1cc(C)ccc1N1CCN(C(=O)[C@H](C)Cc2ccc(Cl)cc2)CC1)C(C)C,-4.9204097,1.201130790291211e-05,1
11e,Cc1ccc(N2CCN(C(=O)[C@H](C)Cc3ccc(Cl)cc3F)CC2)c([C@@H](NC(=O)CCN(C)C)C(C)C)c1,-4.4308991,3.7076685234951906e-05,1
12c,COc1cc(Cl)ccc1C[C@@H](C)C(=O)N1CCN(c2ccc(Cl)cc2[C@@H](NC(=O)C(C)N)C(C)C)CC1,-5.521439099999999,3.009961218413622e-06,0
"3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol (18)",Oc1ccc(-c2cnc(-c3cccc(O)c3)o2)cc1,-5.1011863,7.921614428207836e-06,0
20,O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1,-5.1515226,7.054681316463142e-06,0
N-(4-(Chlorodifluoromethoxy)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide (22),O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1ccnn1CCc1ccncc1,-5.3275695,4.703601281295663e-06,0
N-(4-tert-Butylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide (23),CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,-5.1295056,7.42154627981762e-06,0
24,CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,-5.0886235,8.154108763735228e-06,1
1,Cc1cc(COc2ccc(C(=O)N[C@@H]3CC4(C[C@@H]3C(=O)NO)OCCO4)cc2)c2ccccc2n1,-5.7423639,1.8098229870351462e-06,0
"18 (5R,S)",Cc1cc(COc2ccc(C(=O)N[C@@H]3C[C@@]4(CCCO4)C[C@@H]3C(=O)NO)cc2)c2ccccc2n1,-5.6319547,2.33370147122987e-06,0
4-(Pyridin-4-ylmethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide (3),O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1,-5.158072,6.949091017500826e-06,0
9,O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1,-5.1003633000000015,7.936640338403553e-06,0
N-(3-tertbutylphenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide (11),CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1,-5.2516832,5.601660706541577e-06,0
14,O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1,-5.2606096,5.487700486959434e-06,0
4-(quinolin-4-ylmethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide (30),O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12,-5.5700002,2.691533564429618e-06,0
6,Cn1c(NCCCN2CCC(CN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.8989701,1.2619144109928451e-06,0
6b,CN(CCCN1CCC(CN2c3ccccc3Sc3ccc(C(=O)O)cc32)CC1)c1cc(=O)n(C)c(=O)n1C,-5.7209244,1.9014092397532527e-06,0
22,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-4.8289509000000015,1.4826857035614904e-05,1
24,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4c(C(=O)O)cccc43)CC2)cc(=O)n(C)c1=O,-5.8005152,1.5830141613597583e-06,0
25,Cn1c(N2CCN(CCN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.3099999,4.8977893214419975e-06,0
28,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(CC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.2600002,5.495406207847575e-06,0
30,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(CCC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.1100001,7.762469378912089e-06,0
32,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(C(C)(C)C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.0,1e-05,1
34,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(OCC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.8005152,1.5830141613597583e-06,0
35,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4ccc(/C=C/C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-4.6493707,2.2419674345071147e-05,1
KAR-2,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@]5(C[C@]6(CC)C=CCN7CC[C@]43[C@@H]76)OC(=O)N(CCCl)C5=O)C2)C1,-4.8616409,1.3751785828756436e-05,1
11-keto-beta-boswellic acid (KBA),C[C@H]1C[C@@]2(C)C(=CC(=O)[C@@H]3[C@]4(C)CC[C@@H](O)[C@@](C)(C(=O)O)[C@H]4CC[C@]32C)[C@@H]2[C@@H](C)[C@H](C)CC[C@H]12,-5.8000002,1.5848924625909923e-06,0
Bis(7)-tacrine (B7T),c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,-5.441246499999999,3.6203745225650457e-06,0
1,Cc1c(O)c2c(c(C)c1CCO)C(=O)C(C)(C)C2,-4.7597256,1.7388991692619408e-05,1
"Quercetin 3,4'-diglucoside",O=c1c(OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c2)oc2cc(O)cc(O)c12,-7.0478787,8.956148790538294e-08,0
D-Glu(OBzl)-Ala,CC(NC(=O)[C@@H](N)CCC(=O)OCc1ccccc1)C(=O)O,-5.6912522,2.0358594864129354e-06,0
D-Ser(Bzl)-Ala,CC(NC(=O)[C@@H](N)COCc1ccccc1)C(=O)O,-5.9906998,1.0216454378408603e-06,0
Glycocholate,C[C@H](CCC(=O)NCC(=O)[O-])[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,-5.7141905,1.931121059516432e-06,0
F-(S)-IZD,O=C1C[C@@H](c2ccc(C[C@H](NS(=O)(=O)c3ccccc3)c3nc4ccccc4[nH]3)cc2F)S(=O)([O-])=N1,-6.521439099999999,3.009961218413622e-07,0
Epigallocatechin (EGC),Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2,-6.8284068,1.484544430499143e-07,0
DB377 (4),CCO/N=C(\N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/OCC)cc3)o2)cc1,-5.2295737,5.894219433667589e-06,0
NS5B inhibitor 2,CC(C)CCn1c(=O)c(C2=NS(=O)(=O)c3ccccc3N2)c(O)c2cccn21,-4.9593034000000005,1.0982383373298045e-05,1
Deoxynivalenol (DON),CC1=C[C@@H]2O[C@@H]3[C@@H](O)C[C@](C)([C@]34CO4)[C@]2(CO)[C@@H](O)C1=O,-5.3005152,5.005930318198146e-06,0
[D-Ala2]Met-enkephalin,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,-7.02,9.549925860214369e-08,0
Metkephamid,CN[C@@H](CCSC)C(=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1,-7.309999900000001,4.897789321441988e-08,0
Oxazolidin-2-one (OXa),CC(=O)NCC1CN(c2ccc(C(C)=O)cc2)C(=O)O1,-4.5900002,2.5703945990581314e-05,1
OXb,CC(=O)c1ccc(N2CC(CO)OC2=O)cc1,-4.1799998,6.606937522682428e-05,1
OXd,CCCOCOCC1CN(c2ccc(C(C)=O)cc2)C(=O)O1,-3.95,0.0001122018454301963,1
OXe,CC(=O)NC(O)CNc1ccc(C(C)=O)cc1,-5.2199998,6.025598635633657e-06,0
OXf,CC(=O)NCC1CN(c2ccc(C(C)=O)cc2)S(=O)N1C,-5.119999900000002,7.5857774969814265e-06,0
OXh,CC(=O)NCC1CN(c2ccc(C(C)O)cc2)C(=O)N1,-5.6999998,1.9952632338213455e-06,0
OXn,CC(=O)c1ccc2c(c1)N1C(=O)OCC1CC2,-4.0100002,9.772367709215421e-05,1
5'-L-valyl-cytarabine (2),CC(C)[C@H](N)C(=O)OC[C@H]1O[C@@H](n2ccc(O)nc2=O)[C@@H](O)[C@@H]1O,-5.23,5.888436553555884e-06,0
E17,CC(C)S(=O)(=O)n1c(N)nc2ccc(/C(=C/C(N)=O)c3cc(F)c(F)c(F)c3)cc21,-4.329999900000002,4.677352489872053e-05,1
E23,CNC(=O)/C=C(\c1cccc(F)c1)c1ccc2nc(N)n(S(=O)(=O)NC(=O)N3CCOCC3)c2c1,-4.3899999,4.073803716068987e-05,1
E24,CNC(=O)/C=C(\c1cccc(F)c1)c1ccc2nc(N)n(S(=O)(=O)NC(=O)N3CCCC3)c2c1,-4.099999899999999,7.94328417625139e-05,1
E28,CNC(=O)/C=C(/c1ccc2nc(N)n(C3CCCC3)c2c1)c1ccccc1F,-5.1500001,7.0794562137361614e-06,0
Naringin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,-6.820000200000001,1.513560551415652e-07,0
13,CCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,-5.46,3.467368504525317e-06,0
14,CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,-5.3200002,4.78629871905386e-06,0
VX-950,CCC[C@H](NC(=O)C1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,-5.3200002,4.78629871905386e-06,0
BILN-2061,COc1ccc2c(O[C@@H]3CC4C(=O)N[C@]5(C(=O)O)C[C@@H]5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1,-5.6599998,2.187762631451247e-06,0
4f,NCc1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2ccc(-c3ccccc3S(N)(=O)=O)cc2F)c1,-6.0,1e-06,0
4g,CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2cccc(CN)c2)cc1,-5.5,3.162277660168379e-06,0
4h,CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2cccc(CN)c2)c(F)c1,-5.3000002,5.011870028220744e-06,0
4c,COC(=O)/C=C/CNC(=O)CN1C(=O)[C@@H](COC(=O)Nc2ccc(Cl)cc2C(F)(F)F)N=C(c2ccccc2)c2ccccc21,-5.420000099999998,3.80189308778729e-06,0
1-naphthol,Oc1cccc2ccccc12,-4.4899998,3.235938059500489e-05,1
I-II,O=C(O)C[C@@H](c1cnc2ccccc2c1)N1CC[C@@H](CCCc2ccc3c(n2)NCCC3)C1=O,-5.6900001,2.041737474542049e-06,0
5'-L-Val-FUdR,CC(C)C(N)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-5.29,5.128613839913648e-06,0
5'-L-Leu-FUdR,CC(C)[C@H](N)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-6.0100002,9.772367709215421e-07,0
Methylparaben,COC(=O)c1ccc(O)cc1,-4.46,3.467368504525317e-05,1
Butylparaben,CCCCOC(=O)c1ccc(O)cc1,-4.4899998,3.235938059500489e-05,1
Octylparaben,CCCCCCCCOC(=O)c1ccc(O)cc1,-4.880000099999998,1.3182564350166154e-05,1
2,NC(=O)c1c(F)ccc(OCc2nc3cc(Cl)cnc3s2)c1F,-4.3099999,4.897789321441998e-05,1
6,CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(C)=O,-5.380000099999998,4.168692874826252e-06,0
Pyrilamine Maleate,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,-4.6599998,2.187762631451247e-05,1
Org 12962,FC(F)(F)c1ccc(N2CCNCC2)nc1Cl,-4.5999999,2.5118870098928704e-05,1
Org 33062,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,-4.6999998,1.9952632338213456e-05,1
Org 25907,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1O,-4.8899999,1.2882498483235886e-05,1
Org 34037,Clc1ccc(C2CN3CCN=C3c3ccccc32)cc1,-4.7199998,1.905461595460538e-05,1
Org 34167,C=CCC(N)c1ccccc1-c1noc2ccccc12,-4.869999900000002,1.3489631932018668e-05,1
2,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)C(C)C,-5.8499999,1.4125378698715802e-06,0
21e,CC(C)[C@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)C(=O)NCC(F)(F)F,-5.54,2.884031503126606e-06,0
Teniposide,COc1cc([C@@H]2c3cc4c(cc3[C@@H](OC3OC5COC(c6cccs6)OC5C(O)C3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,-6.0500002,8.912505276976144e-07,0
22,O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21,-5.8200002,1.5135605514156553e-06,0
1,CN1C(=O)CC(N2CCN(CCCN3c4ccccc4Sc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-4.9099998,1.2302693373722196e-05,1
13,CN1C(=O)CC(N2CCN(CCCN3c4ccccc4COc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.119999900000002,7.5857774969814265e-06,0
13d,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4COc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.8000002,1.5848924625909923e-06,0
13e,CC(C(=O)O)c1ccc2c(c1)N(CCCN1CCCN(C3CC(=O)N(C)C(=O)N3C)CC1)c1ccccc1CO2,-5.7199998,1.9054615954605379e-06,0
13g,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4COc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.5,3.162277660168379e-06,0
13i,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4CCc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.5900002,2.5703945990581314e-06,0
13j,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4CCc4ccc(C(C)(C)C(=O)O)cc43)CC2)N(C)C1=O,-5.2450004,5.688524069111708e-06,0
(E-Z)-19a,CN1C(=O)CC(N2CCN(CC/C=C3/c4ccccc4COc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.1399999,7.24436126882553e-06,0
(Z)-19b,CN1C(=O)CC(N2CCCN(CC/C=C3/c4ccccc4COc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.4000001,3.981070788859444e-06,0
(Z)-19c,CN1C(=O)CC(N2CCN(CC/C=C3/c4ccccc4COc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.0700002,8.51137646238915e-06,1
(Z)-19e,CN1C(=O)CC(N2CCN(CC/C=C3/c4ccccc4CCc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-4.829999900000002,1.4791087287455338e-05,1
(Z)-19g,CN1C(=O)CC(N2CCCN(CC/C=C3/c4ccccc4CCc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.1599998,6.918312895189466e-06,0
T2000,COCN1C(=O)N(COC)C(=O)C(c2ccccc2)(c2ccccc2)C1=O,-4.4499998,3.548135526312176e-05,1
CD21,CCCCCCCCCC(=O)NN,-4.1199999,7.585777496981457e-05,1
CD27,CCCCCCCCCC(=O)N1CCNCC1,-3.8199999,0.0001513561596946605,1
Zearalenone (ZEN),CC1CCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)OC1,-4.98,1.0471285480508985e-05,1
a-Zearalenol (a-ZEL),CC1CCC(O)CCC/C=C/c2cc(O)cc(O)c2C(=O)OC1,-5.27,5.370317963702533e-06,0
a-Zearalanol (a-ZAL),CC1CCC(O)CCCCCc2cc(O)cc(O)c2C(=O)OC1,-4.8200002,1.5135605514156553e-05,1
Telaprevir,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,-5.3899999,4.073803716068988e-06,0
Tryptanthrin,O=C1c2ccccc2-n2c1nc1ccccc1c2=O,-4.1999998,6.309576350468559e-05,1
6,COC(=O)C[C@@H](C(=O)NN(Cc1ccc(Br)cc1)C[C@@](O)(Cc1ccccc1)C(=O)NC1CCOC1)C(C)(C)C,-4.9699998,1.0715197986905956e-05,1
10,CNC(=O)[C@H](NC(=O)[C@](O)(Cc1ccccc1)CN(Cc1ccc(Br)cc1)NC(=O)[C@H](CC(=O)OC)C(C)(C)C)C(C)(C)C,-5.5999999,2.5118870098928704e-06,0
25,CN1CCCC/C=C\[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](Oc3nc(-c4ccccc4)nc4ccccc34)C[C@H]2C1=O,-4.6799998,2.0892970930106858e-05,1
45a,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccccc3)nc2c1,-4.8899999,1.2882498483235886e-05,1
45c,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccc(F)cc3)nc2c1,-4.6999998,1.9952632338213456e-05,1
51a,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccccc3)nc2c1C,-4.8899999,1.2882498483235886e-05,1
51e,COc1ccc(-c2nc(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)c3ccc(OC)c(C)c3n2)cc1,-5.0500002,8.912505276976144e-06,1
60c,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccc(F)cc3)nc2c1C,-4.4899998,3.235938059500489e-05,1
Amfenac,Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1,-4.52,3.0199517204020192e-05,1
Levofloxacin,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,-4.5500002,2.8183816333514456e-05,1
Paraoxon,CCOP(=O)(OCC)Oc1ccc(N(O)O)cc1,-4.6900001,2.041737474542049e-05,1
Sulfasalamide,NC(=O)Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,-5.7088718,1.9549164451498206e-06,0
Amlodipine,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,-4.670000099999998,2.1379615972183328e-05,1
Dronedarone,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,-4.52,3.0199517204020192e-05,1
Trimethobenzamide,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,-4.96,1.0964781961431852e-05,1
Desloratadine,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,-4.059999899999998,8.709637905028848e-05,1
corticosterone,C[C@]12C[C@@H](O)[C@@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@H]1CC[C@H]2C(=O)CO,-4.4850001,3.2734061950586664e-05,1
daidzin ,O=c1c(-c2ccc(O)cc2)coc2cc(OC3OC(CO)C(O)C(O)C3O)ccc12,-6.3600001,4.36515731728693e-07,0
desoxycarticosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,-4.670000099999998,2.1379615972183328e-05,1
"(2E,9Z)-N-(2-methylbutyl)pentadeca-2,9-diene-12,14-diynamide",C#CC#CC/C=C\CCCCC/C=C/C(=O)NCC(C)CC,-4.4299998,3.715354001955079e-05,1
EACV,C=C1NC(N)=Nc2c1ncn2COCCOC(=O)CC[C@@H](N)C(=O)O,-5.8099999,1.5488169755407276e-06,0
ganciclovir,Nc1nc(=O)c2ncn(COC(CO)CO)c2[nH]1,-6.369999900000002,4.265796170251665e-07,0
hexapeptide 04,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 15,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 16,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O,-5.3000002,5.011870028220744e-06,0
hexapeptide 19,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 43,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
hexapeptide 51,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
indobufen,CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1,-4.3899999,4.073803716068987e-05,1
IRR ,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)ccc1O,-6.54,2.8840315031266057e-07,0
isovitexin ,O=c1cc(-c2ccc(O)cc2)oc2cc([O-])c(C3OC(CO)C(O)C(O)C3O)c(O)c12,-6.1999998,6.309576350468559e-07,0
kaempferide ,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,-5.1900001,6.456540803672927e-06,0
neolignan smi07,C=CCc1cc(OC)c(OC(C)C(O)c2ccc(OC)c(OC)c2)c(OC)c1,-4.619999900000002,2.3988334713712372e-05,1
neolignan smi10,C=CCc1cc(OC)c(OC(C)C(O)c2cc(O)cc(OC)c2)c(OC)c1,-4.6500001,2.2387206230838082e-05,1
nitrendipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,-4.8499999,1.4125378698715803e-05,1
omeprazole,COc1ccc2[nH]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1,-4.1700001,6.760828197181412e-05,1
ouabain,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,-7.23,5.8884365535558836e-08,0
quercitrin ,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,-6.0999999,7.943284176251373e-07,0
saquinavir,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,-6.2600002,5.495406207847576e-07,0
SB209670,CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCC(=O)O)[C@H](C(=O)O)C2,-5.23,5.888436553555884e-06,0
SDZ-RAD,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC3[C@H](C[C@@H]4CC[C@@H](OCCO)[C@H](OC)C4)[C@H](CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)CC[C@H](C)/C=C/C=C/C=C/1C)OC(=O)[C@H]32,-4.630000099999998,2.3442282755413603e-05,1
sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,-4.880000099999998,1.3182564350166154e-05,1
betazolol ester,CC(C)NC[C@H](COc1ccc(CCOCC2CC2)cc1)OC(=O)C1CC1,-4.52,3.0199517204020192e-05,1
caffeine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,-4.3400002,4.570879791180328e-05,1
74,Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,-5.6989698,2.0000009410023614e-06,0
Verapamil,COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,-4.961279900000001,1.0932515455814692e-05,1
2f,COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.7447276,1.799999564383302e-05,1
2g,COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1,-4.5686364,2.6999989794270932e-05,1
31,CNCc1cnc(C)cc1Oc1ccccc1Oc1ccccc1,-4.8399267,1.445683751918309e-05,1
943-Ketotifen fumarate (38),CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,-3.9546771,0.0001109999798631607,1
882-13i,C[C@@H]1O[C@@H](c2ccc(N(O)O)cc2)OC[C@H]1NC(=O)Cc1ccccc1,-4.9846401,1.0360003449182184e-05,1
061-Amiloride,NC(N)=NC(=O)c1nc(Cl)c(N)nc1N,-5.5642352,2.7275002558570867e-06,0
187-Saquinavir,CC(C)(C)NC(=O)[C@H]1C[C@H]2CCCC[C@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,-5.8616972,1.3750003224111408e-06,0
Acyclovir,Nc1nc(=O)c2ncn(COCCO)c2[nH]1,-5.9899998,1.0232934635247015e-06,0
Atropine,CN1[C@@H]2CC[C@@H]1CC(OC(=O)C(CO)c1ccccc1)C2,-4.7016673,1.987616988142739e-05,1
Bendroflumethiazide,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,-5.8899999,1.2882498483235886e-06,0
Cisapride,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,-4.52,3.0199517204020192e-05,1
Cymarin,COC1CC(OC2CCC3(C=O)C4CCC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)OC(C)C1O,-5.579999900000002,2.630268597537029e-06,0
Diphenhydramine,CN(C)CCOC(c1ccccc1)c1ccccc1,-4.27,5.3703179637025325e-05,1
Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-4.4699998,3.3884431218273894e-05,1
Ketoconazole,CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,-4.7538648,1.762524651690296e-05,1
Ketotifen,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,-4.9499998,1.1220189710106768e-05,1
Methadone,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,-4.6599998,2.187762631451247e-05,1
Methyldopa,C[C@@](N)(Cc1ccc(O)c(O)c1)C(=O)O,-6.619894,2.399418483270603e-07,0
Talinolol,CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1,-4.9684534000000005,1.0753419788972589e-05,1
Terfenadine,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,-5.2600002,5.495406207847575e-06,0
"Maraviroc (UK-427,857)",Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,-6.0,1e-06,0
N-Acetyl-D-leucyl-D-phenylalanine N-Methylamide (4),CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(C)=O,-5.2142239,6.106271356537066e-06,0
10,N=C(N)c1cccc(CC(CC(=O)N2CCNCC2)NS(=O)(=O)c2ccc3ccccc3c2)c1,-7.0312262,9.306230390942389e-08,0
Corticosterone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,-4.3887606,4.0854452989857e-05,1
Sucrose,OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,-5.9186072,1.2061263346970162e-06,0
Doxorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@](O)(C(=O)CO)C[C@H]3O[C@@H]1C[C@@H](N)[C@@H](O)[C@@H](C)O1,-6.5900002,2.5703945990581314e-07,0
Propranolol ester,CC(C)NCC(COc1cccc2ccccc12)OC(=O)C1CC1,-4.1608586,6.904645725228159e-05,1
Proscillaridin,CC1OC(O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)C(O)C(O)C1O,-6.2299852,5.888637224643327e-07,0
Dexamethasone-?-D-glucuronide,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC1O[C@@H](CC(=O)O)[C@H](O)[C@@H](O)[C@@H]1O,-5.9796510000000005,1.0479703610492155e-06,0
U-84656 (IV),CNC(=O)[C@@H]1Cc2cn(cn2)CC(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)N1C,-5.8998151,1.2594615108633126e-06,0
Ac-D-phe3-NH2,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,-5.764868700000001,1.718427839927514e-06,0
PNU200648,Cc1ccnc2nc(Cc3nc4ccc(C(=N)N)cc4[nH]3)[nH]c12,-7.0478787,8.956148790538294e-08,0
PNU-179450,CCC(=O)NC[C@H]1CN(c2ccc(-c3nncs3)c(F)c2)C(=O)O1,-4.4308991,3.7076685234951906e-05,1
PNU-182347,CC(=S)NC[C@H]1CN(c2ccc(-c3nnc(CN)s3)c(F)c2)C(=O)O1,-4.8219547,1.5067642242039618e-05,1
PNU-182945,CNCc1nnc(-c2ccc(N3C[C@H](CNC(C)=S)OC3=O)cc2F)s1,-4.769775900000001,1.6991201881437623e-05,1
PNU-241028,CC(=S)NC[C@H]1CN(c2ccc(-c3nnc(CNS(C)(=O)=O)s3)c(F)c2)C(=O)O1,-5.619894,2.399418483270603e-06,0
NK1NK2 analogue 104 (15f),COc1cc(C(=O)N2CC[C@](CCN3CCC(C(=O)N4CCN(C)CC4)(c4cccnc4)CC3)(c3ccc(Cl)c(Cl)c3)C2)cc(OC)c1OC,-5.1382737,7.2732128943608696e-06,0
341908,CC(C)NS(=O)(=O)n1c(N)nc2ccc(C(C(N)=O)c3cccc(F)c3)cc21,-4.331273599999999,4.6636548342529645e-05,1
"UK 224,671",NS(=O)(=O)N1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,-5.8969545,1.2677846816862934e-06,0
5'-L-glycyl-L-leucyl-floxuridine,CC(C)CC(NC(=O)CN)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-5.2006745,6.299781692103405e-06,0
N-[5-[(4-Dimethylaminobenzoyl)amino]pentyl]-2-mercaptoacetamide (S2),CN(C)c1ccc(C(=O)NCCCCCNC(=O)CS)cc1,-5.1324477,7.3714394069978915e-06,0
Vorinostat (SAHA-suberoylanilide hydroxamic acid),O=C(CCCCCCC(=O)Nc1ccccc1)NO,-5.629466099999999,2.3471124655835106e-06,0
2,CCCCCCC(N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,-5.4504986,3.5440627274999172e-06,0
11,CCCCCCC(N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1O[C@H](C(N)=O)[C@@H](O)C(O)C1O,-5.79,1.6218100973589298e-06,0
PB-43,Cn1cncc1CN1CC(N(CCn2cccc2)S(=O)(=O)c2ccccn2)Cc2cc(C#N)ccc21,-4.9099998,1.2302693373722196e-05,1
-,Oc1ccncc1,-4.1089525,7.781216517233697e-05,1
-,c1ccc(Cc2ccncc2)cc1,-3.9978395,0.00010049871296326983,1
-,Fc1ccncc1,-3.8897052,0.00012891243150373605,1
3'-Cl BZT,CN1C2CC[C@@H]1CC(OC(c1ccccc1)c1cccc(Cl)c1)C2,-4.662271,2.1763513041218048e-05,1
"7,4'-DMF",COc1ccc(-c2cc(=O)c3ccc(OC)cc3o2)cc1,-4.6010299,2.5059367201301492e-05,1
12g,Cn1cncc1CN(CCN(Cc1ccccc1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1,-5.5514212,2.80917503365616e-06,0
"(2E,4Z,8Z)-N-isobutyldodeca-2,4,10-triene-8 -ynamide (4) mw = 245",C/C=C/C#CCC/C=C\C=C\C(=O)NCC(C)C,-4.0,0.0001,1
"2',3'-dideoxyinosine (ddI)",OC[C@@H]1CC[C@H](n2cnc3c(O)ncnc32)O1,-5.6708102,2.1339773228838115e-06,0
CF 1526 (p-OMe),COC(=O)C(C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(OC)cc1,-5.9819288,1.0424883251513388e-06,0
S-nitrosylated captopril (CapNO),C[C@H](CSN=O)C(=O)N1CCC[C@@H]1C(=O)O,-4.5,3.1622776601683795e-05,1
ME3229,CCCCOC(=O)COc1ccc(C(=O)CNC(=O)c2cc3c(s2)CCNC3)cc1OCC(=O)OCCCC,-5.1011863,7.921614428207836e-06,0
10b,CC(C)(NC(=O)c1cc2ccccc2s1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCCCN1CCOCC1,-5.3289509000000015,4.6886638774235375e-06,0
25c,CN1CCN(C(=O)CCNC(=O)[C@@H](Cc2ccccc2)NC(=O)C2(NC(=O)c3cc4ccccc4s3)CCCC2)CC1,-5.6994848,1.9976306828816265e-06,0
25e,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N2CCN(CC3CCOCC3)CC2)CCCC1)c1cc2ccccc2s1,-5.5693183,2.695762948972653e-06,0
21b,CC1CN(CCCNC(=O)[C@@H](Cc2ccccc2)NC(=O)C2(NC(=O)c3cc4ccccc4s3)CCCC2)CC(C)N1,-5.9593034000000005,1.0982383373298045e-06,0
20E 22-methyl ether (4),CO[C@H](CCC(C)(C)O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.79,1.62181009735893e-05,1
PoA 2-methyl ether (16),CO[C@H]1C[C@]2(C)C3CC[C@]4(C)[C@@H]([C@@](C)(O)[C@H](O)CCC(C)C)CC[C@@]4(O)C3=CC(=O)[C@@H]2C[C@H]1O,-4.6999998,1.9952632338213456e-05,1
PoA 3.22-dimethyl ether (20),CO[C@@H]1C[C@H]2C(=O)C=C3C(CC[C@]4(C)[C@@H]([C@@](C)(O)[C@@H](CCC(C)C)OC)CC[C@@]34O)[C@]2(C)C[C@@H]1O,-4.5380535,2.8969866908462757e-05,1
Ponasterone A (26),CC(C)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.7199998,1.905461595460538e-05,1
Folinic acid,Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1)N2C=O,-7.5214391,3.009961218413616e-08,0
Ginsenoside Rg1 (Rg1),CC(C)=CCC[C@](C)(O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,-6.5883503,2.580178190813816e-07,0
Berberrubine (BRB),COc1ccc2cc3[n+](cc2c1O)CCc1cc2c(cc1-3)OCO2,-4.8815303,1.3136198427024185e-05,1
Ajmalicine (AMC),COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]12,-4.8187928,1.5177743182452128e-05,1
Beta-colubrine (Col),COc1ccc2c(c1)[C@]13CCN4CC5=CCO[C@@H]6CC(=O)N2[C@@H]1[C@@H]6[C@@H]5C[C@@H]43,-4.5717444,2.6807455886501698e-05,1
Icajine (Ica),CN1CC[C@]23C(=O)C[C@@H]4C(=CCO[C@H]5CC(=O)N(c6ccccc62)[C@@H]3[C@@H]54)C1,-4.5816798,2.6201140742579533e-05,1
Pyr-His-Pro-NH2 (TRH),NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H]1CCC(=O)N1,-6.8313413,1.4745472719752476e-07,0
Taxifolin (29),O=C1c2c(O)cc(O)cc2OC(c2ccc(O)c(O)c2)C1O,-6.5093193,3.095142865722042e-07,0
11d,Cc1ccc(N2CCN(C(=O)[C@H](C)Cc3ccc(Cl)cc3)CC2)c([C@@H](NC(=O)CCN(C)C)C(C)C)c1,-4.3886080000000005,4.086881072456715e-05,1
11f,Cc1ccc(N2CCN(C(=O)[C@H](C)Cc3ccc(Cl)cc3C)CC2)c([C@@H](NC(=O)CCN(C)C)C(C)C)c1,-4.7979398,1.5924294473524644e-05,1
32,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1,-5.3400002,4.570879791180327e-06,0
3,Cn1c(NCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)cc(=O)n(C)c1=O,-4.8783755,1.323196976961937e-05,1
23,Cn1c(N2CCCN(CCCN3c4ccccc4Sc4cccc(C(=O)O)c43)CC2)cc(=O)n(C)c1=O,-5.8005152,1.5830141613597583e-06,0
27,Cn1c(N2CCN(CCCN3c4ccccc4Sc4ccc(CC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-4.9099998,1.2302693373722196e-05,1
29,Cn1c(N2CCN(CCCN3c4ccccc4Sc4ccc(CCC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.29,5.128613839913648e-06,0
31,CC(C(=O)O)c1ccc2c(c1)N(CCCN1CCCN(c3cc(=O)n(C)c(=O)n3C)CC1)c1ccccc1S2,-5.1599998,6.918312895189466e-06,0
3,CSc1nc2cc(C(=O)N3CCC(C)CC3)ccc2[nH]1,-4.5418172,2.8719891839543348e-05,1
"L1 (1,2-dimethyl-3 hydroxypyridin-4-one)",Cc1c(O)c(=O)ccn1C,-4.8885303,1.2926165139673716e-05,1
Me-(S)-IZD,Cc1cc(C[C@H](NS(=O)(=O)c2ccccc2)c2nc3ccccc3[nH]2)ccc1[C@@H]1CC(=O)N=S1(=O)[O-],-6.3989701,3.990523750927213e-07,0
Acrylamide,C=CC(N)=O,-4.5693183,2.6957629489726532e-05,1
Dihydrotetrabenazine isomer A,COc1cc2c(cc1OC)[C@H]1C[C@H](O)[C@@H](CC(C)C)CN1CC2,-4.6799998,2.0892970930106858e-05,1
Ethylparaben,CCOC(=O)c1ccc(O)cc1,-4.8102908,1.5477798912207607e-05,1
5'-L-phenylalanyl-cytarabine (5),N[C@@H](Cc1ccccc1)C(=O)OC[C@H]1O[C@@H](n2ccc(O)nc2=O)[C@@H](O)[C@@H]1O,-5.6999998,1.9952632338213455e-06,0
Astilbin,C[C@@H]1O[C@@H](O[C@@H]2C(=O)c3c(O)cc(O)cc3O[C@H]2c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,-6.820000200000001,1.513560551415652e-07,0
12,COCCOCCOCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,-6.2399998,5.754402023371028e-07,0
S1,C=CCNC(=O)C(=O)C(CCC)NC(=O)C1CC2CN1C(=O)C(C1CCCCC1)NC(=O)Cc1cccc(c1)OCCC(C)(C)O2,-5.0300002,9.33253871017602e-06,1
S2,C=CCNC(=O)C(=O)C(CCC)NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC(C(=O)C(C)C)C(C)C)C(C)(C)C)C2(C)C,-5.29,5.128613839913648e-06,0
II,CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)OC(C)(C)C,-4.1799998,6.606937522682428e-05,1
3'-L-Ile-FUdR,CC[C@H](C)[C@H](N)C(=O)O[C@@H]1C[C@@H](n2cc(F)c(=O)[nH]c2=O)O[C@H]1CO,-5.5599999,2.7542293375228335e-06,0
5'-L-Asp-FUdR,NC(CC(=O)O)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-6.4899998,3.23593805950049e-07,0
Acetyl-Trp-Ala-Gly-Gly-Asn-Ala-Amide,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O,-7.29,5.128613839913648e-08,0
Daunorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,-6.0999999,7.943284176251373e-07,0
24,COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1,-5.6999998,1.9952632338213455e-06,0
13c,CN1C(=O)CC(N2CCN(CCCN3c4ccccc4COc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.52,3.0199517204020193e-06,0
13h,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4CCc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.3600001,4.36515731728693e-06,0
(Z)-19f,CN1C(=O)CC(N2CCCN(CC/C=C3/c4ccccc4CCc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.3200002,4.78629871905386e-06,0
Ac-C8-Enk-NH (3),CCCCCC[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O,-5.9699998,1.0715197986905958e-06,0
Apometzgerin (2),COc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc(O)c1OC,-4.9499998,1.1220189710106768e-05,1
Cycloheximide,C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1,-4.8400002,1.4454391050964657e-05,1
